39068-23-0

Usage

InChI:InChI=1/C10H14O.Na/c1-10(2,3)8-6-4-5-7-9(8)11;/h4-7,11H,1-3H3;/q;+1/p-1

Upstream product

• 88-18-6 2-tert-Butylphenol 

Downstream Products

• 210487-91-5 methoxymesityldichlorogermane 
• 60803-26-1 2-(tert-butyl)-4,6-diiodophenol 
• 1355646-93-3 1-(3-tert-butyl-5-(6-hydroxynaphthalen-2-yl)-4-methoxyphenyl)-pyrimidine-2,4(1H,3H)-dione 
• 1355646-97-7 6-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate 
• 1132935-63-7 N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide 
• 1132940-51-2 1-tert-butyl-3,5-diiodo-2-methoxybenzene 
• 1132940-53-4 1-(3-tert-butyl-5-iodo-4-methoxyphenyl)-2,4-dihydropyrimidine-2,4(1H,3H)-dione 
• 123557-93-7 2,4-di(2-hydroxyhexafluoroisopropyl)-6-tert-butylphenol 
• 16878-08-3 2-(2-hydroxyhexafluoroisopropyl)-6-tert-butylphenol 

Relevant academic research and scientific papers

PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS

This disclosure is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.

PROCESS FOR PREPARING ANTIVIRAL COMPOUND

This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.